Company research

iRadimed Corporation (IRMD) stock fundamentals

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internation

As of 2026-10-08

Exchange
XNAS
Sector
Healthcare
Industry
Medical Devices

Company overview

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Daily valuation snapshot

These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing IRMD with another company.

Daily close (USD)$85.88
Market capitalization (USD)$1,098,146,787.08
Price / earnings (TTM)47.63
Price / book10.79

Read IRMD's valuation metrics

  1. Company size

    iRadimed Corporation's recorded market capitalization is $1,098,146,787.08. It measures the market value of the company's equity, rather than its revenue or cash balance.

  2. Price relative to earnings

    IRMD's recorded P/E is 47.63: about $47.63 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.

  3. Price relative to book equity

    IRMD's recorded price-to-book ratio is 10.79. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.

Research iRadimed Corporation with Aurora

Use the snapshot above to ask a specific question about IRMD. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow IRMD's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.